Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

177 Views

241. PK/PD Studies: Saturday, 12:15 - 1:30 p.m.

Poster Session: PK/PD Studies

(2561) Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

AC

Anthony P. Cammarata, M.S.

Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
KL

Karine Litherland, Ph.D.

Basilea Pharmaceutica International Ltd
Allschwil,, Basel-Landschaft, Switzerland
MS

M. Courtney Safir, PharmD

Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Sujata M. Bhavnani, PharmD; MS; FIDSA

Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
MS

Mikael Saulay, MSc

Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland
JS

Jennifer Smart, PhD

Sr. Microbiologist, Development
Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland
MJ

Mark E. Jones, PhD

Basilea Pharmaceutica International Ltd., Allschwil, Switzerland
Allschwil,, Basel-Landschaft, Switzerland
Marc Engelhardt, MD (he/him/his)

Dr.
Basilea Pharmaceutica International Ltd., Allschwil, Switzerland
Allschwil, Basel-Landschaft, Switzerland